- JP-listed companies
- Carna Biosciences, Inc.
- Income statement
Carna Biosciences, Inc.【JP:4572】Income statement
Market cap
¥5.9B
P/E ratio
-2.8x
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 593 | 511 | 771 | 612 | 1,569 | 812 | 658 | 755 | 3,207 | 1,133 | 2,018 | 1,387 | 1,626 | 636 | 579 |
| Revenue growth (%) | - | ||||||||||||||
| Cost of revenue | - | - | - | 233 | 270 | 254 | 223 | 251 | 208 | 192 | 135 | 172 | 175 | 171 | 191 |
| Gross profit | - | - | - | 379 | 1,300 | 557 | 435 | 504 | 3,000 | 941 | 1,882 | 1,215 | 1,451 | 466 | 388 |
| Gross margin (%) | - | - | - | ||||||||||||
| Operating margin (%) | - | - | - | ||||||||||||
| Operating expenses | - | - | - | 1,014 | 827 | 981 | 1,134 | 1,649 | 2,022 | 1,998 | 2,413 | 2,485 | 2,568 | 2,542 | 2,463 |
| Operating income | - | - | - | -635 | 473 | -424 | -699 | -1,145 | 978 | -1,057 | -531 | -1,270 | -1,117 | -2,076 | -2,074 |
| Income before tax | -340 | -443 | -276 | -607 | 492 | -441 | -711 | -1,159 | 957 | -1,077 | -523 | -1,279 | -1,126 | -2,081 | -2,144 |
| Pretax margin (%) | -57.4 | -86.7 | -35.8 | -99.3 | 31.4 | -54.3 | -108.2 | -153.6 | 29.8 | -95 | -25.9 | -92.2 | -69.3 | -327 | -370.3 |
| Provision for income taxes | - | - | - | 2 | 30 | 1 | 4 | 4 | 85 | 9 | 2 | 26 | 22 | 5 | 2 |
| Effective tax rate (%) | - | - | - | ||||||||||||
| Net income | -362 | -450 | -282 | -847 | 456 | -290 | -737 | -1,211 | 828 | -1,111 | -534 | -1,350 | -1,153 | -2,179 | -2,142 |
| Earnings per share | -61.6 | -73.28 | -36.59 | -102.18 | 52.61 | -31.64 | -78.53 | -125.02 | 76.05 | -90.33 | -42.1 | -99.1 | -68.62 | -121.64 | -113.62 |
| Diluted EPS | - | - | - | - | 50.05 | - | - | - | 74.51 | - | - | - | - | - | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |